Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANDU PHARMA vs BERYL DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANDU PHARMA BERYL DRUGS SANDU PHARMA/
BERYL DRUGS
 
P/E (TTM) x 48.8 12.6 387.2% View Chart
P/BV x 1.4 1.8 76.6% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 SANDU PHARMA   BERYL DRUGS
EQUITY SHARE DATA
    SANDU PHARMA
Mar-23
BERYL DRUGS
Mar-23
SANDU PHARMA/
BERYL DRUGS
5-Yr Chart
Click to enlarge
High Rs8618 477.8%   
Low Rs508 670.0%   
Sales per share (Unadj.) Rs67.653.0 127.6%  
Earnings per share (Unadj.) Rs1.61.5 104.2%  
Cash flow per share (Unadj.) Rs2.13.1 67.7%  
Dividends per share (Unadj.) Rs0.750-  
Avg Dividend yield %1.10-  
Book value per share (Unadj.) Rs40.615.9 255.3%  
Shares outstanding (eoy) m9.665.07 190.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.00.2 418.8%   
Avg P/E ratio x43.38.4 512.7%  
P/CF ratio (eoy) x32.34.1 789.6%  
Price / Book Value ratio x1.70.8 209.2%  
Dividend payout %47.60-   
Avg Mkt Cap Rs m65865 1,017.8%   
No. of employees `000NANA-   
Total wages/salary Rs m11115 746.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m653269 243.0%  
Other income Rs m33 117.6%   
Total revenues Rs m657272 241.8%   
Gross profit Rs m2520 125.1%  
Depreciation Rs m58 63.5%   
Interest Rs m15 17.1%   
Profit before tax Rs m2210 225.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m72 319.3%   
Profit after tax Rs m158 198.6%  
Gross profit margin %3.87.4 51.5%  
Effective tax rate %31.422.1 141.8%   
Net profit margin %2.32.8 81.7%  
BALANCE SHEET DATA
Current assets Rs m255104 245.4%   
Current liabilities Rs m13964 216.1%   
Net working cap to sales %17.814.8 120.3%  
Current ratio x1.81.6 113.5%  
Inventory Days Days6514 456.9%  
Debtors Days Days268937 28.6%  
Net fixed assets Rs m28671 404.9%   
Share capital Rs m9751 189.7%   
"Free" reserves Rs m29630 995.0%   
Net worth Rs m39281 486.5%   
Long term debt Rs m027 0.0%   
Total assets Rs m542175 309.9%  
Interest coverage x28.73.1 923.7%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x1.21.5 78.4%   
Return on assets %3.07.1 41.9%  
Return on equity %3.99.5 40.8%  
Return on capital %5.913.4 43.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m00-   
Fx outflow Rs m00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m225 8.9%  
From Investments Rs m5-13 -41.2%  
From Financial Activity Rs m6-12 -49.6%  
Net Cashflow Rs m130 11,141.7%  

Share Holding

Indian Promoters % 42.9 26.4 162.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 57.1 73.6 77.6%  
Shareholders   10,021 6,852 146.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANDU PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on SANDU PHARMA vs BERYL DRUGS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SANDU PHARMA vs BERYL DRUGS Share Price Performance

Period SANDU PHARMA BERYL DRUGS S&P BSE HEALTHCARE
1-Day -0.45% -0.98% 1.18%
1-Month -15.08% -25.48% -0.75%
1-Year 9.73% 141.20% 61.82%
3-Year CAGR 19.30% 61.60% 18.16%
5-Year CAGR 21.14% 28.53% 19.79%

* Compound Annual Growth Rate

Here are more details on the SANDU PHARMA share price and the BERYL DRUGS share price.

Moving on to shareholding structures...

The promoters of SANDU PHARMA hold a 42.9% stake in the company. In case of BERYL DRUGS the stake stands at 26.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SANDU PHARMA and the shareholding pattern of BERYL DRUGS.

Finally, a word on dividends...

In the most recent financial year, SANDU PHARMA paid a dividend of Rs 0.8 per share. This amounted to a Dividend Payout ratio of 47.6%.

BERYL DRUGS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of SANDU PHARMA, and the dividend history of BERYL DRUGS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.